Combination CurQD and Vedolizumab in Ulcerative Colitis | MicrobiomeTrials← Back to trialsNCT07665294
Combination CurQD and Vedolizumab in Ulcerative Colitis
RecruitingPHASE4INTERVENTIONAL
Trial Details
Start: 2026-10-01Est. Completion: 2027-06-23
Enrollment target: 160 participants Locations- Icahn School of Medicine at Mount Sinai, New York, New York, United States
Other microbiome trials you might be interested in
Inflammatory Bowel DiseaseCrohn's DiseaseUlcerative Colitis
Background:
Inflammatory bowel disease (IBD) is a term used to describe disorders that cause long-term inflammation in …
Bethesda, United StatesEst. completion Jun 1, 2036
Ulcerative ColitisCrohn's Disease
More older people (more than 65 years of age) around the world are getting Ulcerative Colitis (UC) or Crohn's Disease (C…
Cambridge, United StatesEst. completion Dec 15, 2026